 Home > Medical News > Latest Medical News > Delaying COVID-19 surgery for seven weeks can reduce the risk of death

Delaying COVID-19 surgery for seven weeks can reduce the risk of death

 Last Update: 2021-03-30
 Source: Internet
 Author: User

Tags

university hawaii engineering

new awakenings albuquerque

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

CUHK's participation in the study found that delaying the operation of COVID-19 patients by seven weeks can reduce the risk of death

CUHK's participation in the study found that postponing surgery for COVID-19 patients by seven weeks can reduce the risk of death.

China News Service, Hong Kong, March 23 (Reporter Han Xingtong) The Chinese University of Hong Kong (CUHK) announced on the 23rd that a joint study by CUHK and overseas surgical experts found that if a patient diagnosed with new coronary pneumonia undergoes surgery within six weeks after diagnosis, they will Increasing the risk of postoperative death, research suggests that the operation should be postponed to the seventh week or later after diagnosis.

Hong Kong Hong Kong

It is reported that the study was conducted by 45 experts from the Department of Surgery, Department of Anesthesiology and Intensive Care Medicine of the Faculty of Medicine of CUHK, and doctors from the New Territories East Network of the Hong Kong Hospital Authority, together with the COVIDSurg Collaborative composed of more than 15,000 surgical experts around the world.

Hong Kong

The study collected 140,727 patient data from 116 countries and 1674 hospitals, covering Asia, America, Europe, Africa and Oceania.

The research team found that patients undergoing surgery within six weeks of diagnosis and their symptoms have not resolved will have a higher risk of postoperative death.

Professor Wu Zhaowen of the Department of Surgery at the Faculty of Medicine of CUHK said that Hong Kong has so far more than 11,000 confirmed cases of new coronary pneumonia.

Hong Kong aspx?id=3570" target="_blank" style="color:#ba1413">focuses on COVID-19

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.